Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
apalutamide felodipine

decreases exposure

Moderate Study
apalutamide lacidipine

decreases exposure

Moderate Study
apalutamide lercanidipine

decreases exposure

Moderate Study
apalutamide nicardipine

decreases exposure

Moderate Study
apalutamide nimodipine

decreases exposure

Moderate Study
aprepitant corticosteroids

increases exposure

Moderate Study
aprepitant dexamethasone

increases exposure

Moderate Study
asenapine dopaminereceptoragonists

decreases effects

Moderate Theoretical
asenapine levodopa

decreases effects

Moderate Theoretical
aspirin pemetrexed

increases exposure

Moderate Theoretical
atazanavir clarithromycin

increases exposure

Moderate Study
atazanavir combinedhormonalcontraceptives

affects exposure

Moderate Study
atazanavir dolutegravir

increases exposure

Moderate Study
atazanavir macrolides

increases exposure

Moderate Study
azithromycin ticagrelor

increases exposure

Moderate Study
belzutifan bosutinib

decreases exposure

Moderate Theoretical
belzutifan cobimetinib

decreases exposure

Moderate Theoretical
belzutifan dasatinib

decreases exposure

Moderate Theoretical
belzutifan everolimus

decreases exposure

Moderate Theoretical
belzutifan ibrutinib

decreases exposure

Moderate Theoretical
belzutifan maraviroc

decreases exposure

Moderate Theoretical
belzutifan sirolimus

decreases exposure

Moderate Theoretical
belzutifan temsirolimus

decreases exposure

Moderate Theoretical
berotralstat alfentanil

increases exposure

Moderate Study
berotralstat aliskiren

increases concentration

Moderate Study
berotralstat antihistamines,non-sedating

increases concentration

Moderate Study
berotralstat atomoxetine

increases exposure

Moderate Study
berotralstat benzodiazepines

increases exposure

Moderate Study
berotralstat betablockers,selective

increases exposure

Moderate Study
berotralstat colchicine

increases concentration

Moderate Study
berotralstat dabigatran

increases concentration

Moderate Study
berotralstat digoxin

increases concentration

Moderate Study
berotralstat docetaxel

increases concentration

Moderate Study
berotralstat eliglustat

increases exposure

Moderate Study
berotralstat everolimus

increases concentration

Moderate Study
berotralstat fentanyl

increases exposure

Moderate Study
berotralstat fexofenadine

increases concentration

Moderate Study
berotralstat loperamide

increases concentration

Moderate Study
berotralstat midazolam

increases exposure

Moderate Study
berotralstat nebivolol

increases exposure

Moderate Study
berotralstat opioids

increases exposure

Moderate Study
berotralstat paclitaxel

increases concentration

Moderate Study
berotralstat sirolimus

increases concentration

Moderate Study
berotralstat talazoparib

increases concentration

Moderate Study
berotralstat taxanes

increases concentration

Moderate Study
berotralstat temsirolimus

increases exposure

Moderate Study
berotralstat thrombininhibitors

increases concentration

Moderate Study
berotralstat topotecan

increases concentration

Moderate Study
bosentan amlodipine

decreases exposure

Moderate Theoretical
bosentan benzodiazepines

decreases concentration

Moderate Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.